4DMedical's CE Mark Approval Paves Way for CTVQ™ Launch in Europe 4DMedical has announced that its imaging technology CTVQ™ has received CE Mark approval, allowing for its commercial launch in the European market, addressing critical healthcare needs.

4DMedical's CE Mark Approval Paves Way for CTVQ™ Launch in Europe #Australia #Melbourne #Imaging_Technology #4DMedical #CTVQ

4DMedical Secures CE Mark for CTVQ™, Paving the Way for EU Market Launch 4DMedical's groundbreaking CTVQ™ technology obtains CE Mark for commercial use in the EU, enhancing lung imaging worldwide.

4DMedical Secures CE Mark for CTVQ™, Paving the Way for EU Market Launch #Australia #Melbourne #CE_Mark #4DMedical #CTVQ

We’re heading to #STR2026!

@4dmedical.bsky.social will be showcasing CT:VQ™, our non-contrast technology that turns routine chest CTs into quantitative ventilation & perfusion maps-no contrast, no radioisotopes.

👉 Secure a demo: docs.google.com/forms/d/e/1F...

#4DMedical #ThoracicRadiology #CTVQ

4DMedical Secures Over $100 Million to Boost U.S. Market Expansion and Technology Leadership 4DMedical announces securing over $100 million in funding to expand U.S. operations and enhance technology dominance in lung imaging.

4DMedical Secures Over $100 Million to Boost U.S. Market Expansion and Technology Leadership #United_States #Los_Angeles #4DMedical #CTVQ #Lung_Imaging

CT:VQ™ - 4DMedical Home Products Software SaaS Software CT:VQ™ Maximum CONTRAST. No INJECTIONS. Non‑contrast ventilation and perfusion from standard chest CTs CT:VQ™ is the world’s first non‑contrast post‑processing tec...

🎯 2026 focus: practical access to regional V/Q insights from paired non-contrast chest CT. 🫁 #CTVQ generates quantitative lobar ventilation + perfusion maps and returns them to PACS. 4dmedical.com/products/sof... #Radiology #Pulmonology